Ipramol Steri-Neb

Ipratropium bromide and salbutamol, the active ingredients in Ipramol Steri‑Neb, are a combination anticholinergic (muscarinic antagonist) and short‑acting β2‑agonist presented as a nebulizer solution for inhalation use. They are prescribed to relieve bronchoconstriction in asthma, chronic obstructive pulmonary disease and acute bronchospasm in both adult and pediatric patients.

GNH USA supplies Ipramol Steri‑Neb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. All batches are manufactured under EU GMP standards and undergo rigorous quality testing before distribution.

Ipramol Steri‑Neb, a bronchodilator combination, is used to manage obstructive airway diseases.

- Asthma: provides rapid bronchodilation to relieve symptoms and improve airflow. - Chronic obstructive pulmonary disease (COPD): reduces bronchospasm and enhances lung function during exacerbations. - Acute bronchospasm: offers immediate relief of airway constriction in emergency situations.

Ipramol Steri‑Neb may cause a range of adverse reactions.

Common Side Effects: - Dry mouth: reduced salivary secretion. - Cough: irritation of the airway. - Throat irritation: mild soreness after inhalation. - Tremor: fine muscle tremor, especially of the hands. - Headache: mild to moderate intensity. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening airway narrowing. - Angioedema: swelling of face, lips or tongue. - Tachycardia: rapid heart rate. - Cardiac arrhythmia: irregular heart rhythm. - Severe allergic reaction: rash, itching, difficulty breathing. - Hyperglycemia: elevated blood glucose levels.

Before using Ipramol Steri‑Neb, consider the following precautions.

- Cardiac history: monitor for tachycardia or arrhythmias. - Hypersensitivity: avoid if known allergy to ipratropium, salbutamol or formulation excipients. - Glaucoma: use with caution as anticholinergic effects may increase intra‑ocular pressure. - Diabetes: monitor blood glucose as β2‑agonist can raise levels. - Store at room temperature: keep in original container, protect from light and moisture.

Ipramol Steri‑Neb can interact with several medicines.

Major Interactions (Avoid): - Beta‑blockers: may diminish bronchodilator effect and precipitate bronchospasm. - MAO inhibitors: increased risk of hypertensive episodes with β2‑agonist activity. - Tricyclic antidepressants: additive cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Theophylline: heightened risk of tachyarrhythmia. - ACE inhibitors: possible increase in cough frequency. - Diabetic medications: potential for hyperglycemia. - Systemic corticosteroids: may enhance tremor and tachycardia.